Protocol for studying the efficiency of ChemoCalc software in helping patients to understand drug treatment costs for breast cancer: A multicenter, open-label, randomized phase 2 study

Sayaka Kuba(University of Nagasaki), Susumu Eguchi(Nagasaki University), Toshiko Hatachi(Japanese Red Cross Society, Japan), Kengo Kanetaka(Nagasaki University), Takeshi Nagayasu(Nagasaki University), Hiroki Moriuchi(National Sagamihara Hospital), Megumi Matsumoto, Michi Morita(Nagasaki University), Xiangyue Meng(Nagasaki University), Hideki Taniguchi(Regenerative Medicine Institute), Kosho Yamanouchi, Ryota Otsubo, Hiroshi Yano(Nagasaki University), Junya Miyamoto(Nagasaki University Hospital), Shigeto Maeda(Nagasaki University), Masahiro Oikawa(Nagasaki University Hospital), Kenichiro Shibata(Japanese Red Cross Society, Japan)
Contemporary Clinical Trials Communications
February 10, 2021
Cited by 2


Related Papers